首页> 外国专利> Chemotherapy and Radiation Therapy Targeting NAD + for the treatment of induced cognitive impairment, neuropathy and inactivity

Chemotherapy and Radiation Therapy Targeting NAD + for the treatment of induced cognitive impairment, neuropathy and inactivity

机译:化疗和放射治疗靶向NAD +,用于治疗诱导的认知障碍,神经病变和不活动

摘要

PROBLEM TO BE SOLVED: To provide a method and a composition for preventing or treating peripheral neuropathy, cognitive deficiency, inactivity, depression, chemotherapy and / or radiotherapy-induced peripheral neuropathy and cognitive deficiency in a subject and improving cognitive performance. To do. A method comprising administering to a subject an effective amount of an agent that increases the level of NAD + in the subject. [Selection diagram] Fig. 1
机译:要解决的问题:提供用于预防或治疗外周神经病变,认知缺乏,不活跃,抑郁,化疗和/或放疗诱导的周围神经病变和认知缺陷的方法和组合物,并改善认知性能。去做。一种方法,包括向受试者施用有效量的试剂,该试剂增加了受试者中NAD +的水平。 [选择图]图1

著录项

  • 公开/公告号JP2021073207A

    专利类型

  • 公开/公告日2021-05-13

    原文格式PDF

  • 申请/专利号JP20210001774

  • 申请日2021-01-08

  • 分类号A61K45;A61K31/706;A61K31/455;A61K31/7076;A61K38/48;A61K38/45;A61K31/192;A61K31/167;A61K31/196;A61K31/616;A61K31/573;A61K31/405;A61K48;A61K45/06;A61P25;A61P25/04;A61P25/08;A61P15;A61P25/28;A61P3;A61P25/24;A61P25/22;A61P9/10;A61P7;A61P29;A61P31;A61P17/02;A61P39/02;A61P3/02;A61P25/30;A61P25/20;A61P27/16;A61P27/02;A61P27;A61P25/02;A61P3/10;A61K51;A61P43;

  • 国家 JP

  • 入库时间 2022-08-24 18:41:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号